Tempus AI, Inc. Class A Common Stock Total Liabilities
Tempus AI, Inc. Class A Common Stock total liabilities. Based on the latest financial reports, Tempus AI, Inc. Class A Common Stock (TEM) has total liabilities worth $1.92 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Tempus AI, Inc. Class A Common Stock (TEM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Tempus AI, Inc. Class A Common Stock (2019–2025)
Total liabilities of Tempus AI, Inc. Class A Common Stock from 2019 to 2025. This chart illustrates how Tempus AI, Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore TEM long-term investments to assets to see how much of total assets are deployed in long-term investments.
Tempus AI, Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of Tempus AI, Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sterling Construction Company Inc
NASDAQ:STRL
|
USA | $1.59 Billion |
|
Phison Electronics
TWO:8299
|
Taiwan | NT$23.65 Billion |
|
Watsco Inc
NYSE:WSO
|
USA | $1.43 Billion |
|
First Horizon Corporation
NYSE:FHN
|
USA | $74.97 Billion |
|
WOORI FIN. GRP SP.ADR/3
F:2WGA
|
Germany | €563.60 Trillion |
|
Mankind Pharma Ltd
NSE:MANKIND
|
India | Rs-165.61 Billion |
|
Elanco Animal Health
NYSE:ELAN
|
USA | $6.97 Billion |
|
CSPC PHARMACEUT.GR. ADR4
F:CVGU
|
Germany | €16.59 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Tempus AI, Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Tempus AI, Inc. Class A Common Stock.
Liquidity & Leverage Metrics
Tempus AI, Inc. Class A Common Stock Total Liabilities Ratios Explained
Tempus AI, Inc. Class A Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tempus AI, Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tempus AI, Inc. Class A Common Stock (2019–2025)
The table below shows the annual total liabilities of Tempus AI, Inc. Class A Common Stock from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.78 Billion | +105.05% |
| 2024-12-31 | $869.78 Million | -55.31% |
| 2023-12-31 | $1.95 Billion | +10.56% |
| 2022-12-31 | $1.76 Billion | +31.49% |
| 2021-12-31 | $1.34 Billion | +5.85% |
| 2020-12-31 | $1.26 Billion | +102.52% |
| 2019-12-31 | $624.59 Million | -- |
About Tempus AI, Inc. Class A Common Stock
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnosti… Read more